Dr Katie Howe was our Research Communications Manager.
She has a PhD in cellular and molecular biology from the University College London (UCL). While with us she was passionate about helping people with MS understand their condition and make decisions about treatment and care.
Researchers are working hard to understand how the new COVID-19 vaccines work in people with MS. And the extent to which some disease-modifying therapies (DMTs) affect how well the vaccines work.
